Exocrine Pancreatic Insufficiency In Acute Recurrent Pancreatitis – Prevalence, Natural History And The Potential Role of Pancreatic Enzyme Replacement Therapy
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2026 - 2030
Project Lead
Dr. Shalini G Hegde
Authors
Dr. Shalini G Hegde
Project Status
ongoing
Project Type
ICMR - PhD